Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01444261 · ClinicalTrials.gov registry record · Phase 4
Prevention of Iron Deficiency in Breastfed Infants
A Phase 4 study of Anemia and Iron-deficiency, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
- Completed
- Registry status
- Phase 4
- Development phase
- 219
- Enrollment target
- 1
- Study location
NCT01444261: Completed Phase 4 study of Anemia and Iron-deficiency, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
NCT01444261 is a Phase 4 study of Anemia and Iron-deficiency that has completed, run by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The registered enrollment target is 219 participants, below the 425-participant average among 72 other Anemia trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01444261, a Phase 4 study of Anemia and Iron-deficiency, has completed, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 219 participants
- Enrollment target
- 1
- Study location
Study Summary
With early screening and appropriate iron supplementation, iron deficiency in the first year of life can be prevented in breastfed infants.
Primary Outcome
Iron deficiency anemia will be defined as plasma ferritin less than 10 ug/L and hemoglobin less than 105 g/L. The expected outcome is there will be no infants with iron deficiency anemia before 5.5 mo of age.
Conditions Studied
Interventions
- OTHER control
- DIETARY_SUPPLEMENT Fer-in-Sol
Study Locations (1)
Iowa
- University of Iowa - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 219 participants |
| Start Date | 2010-12 |
| Est. Completion | 2014-04 |
| Phase | Phase 4 |
Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)305 total trials
What the finished NCT01444261 record still lists
NCT01444261 is an interventional study that assigns participants to a tested intervention. The registered 219 participants enrollment target is mid-sized for trials with a published cap, below the 425-participant average among 72 other Anemia trials with a reported enrollment target (48% lower).
The record links to 2 conditions, with Anemia appearing as the primary indexed condition, and to 2 interventions - of which control is the first listed.
NCT01444261 reports a single indexed study location in Iowa.
Frequently Asked Questions
What is clinical trial NCT01444261 about?
NCT01444261 is a clinical study titled "Prevention of Iron Deficiency in Breastfed Infants". With early screening and appropriate iron supplementation, iron deficiency in the first year of life can be prevented in breastfed infants.
What is the current status of trial NCT01444261?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 219 participants. The study started on 2010-12. Estimated completion is 2014-04.
What conditions does trial NCT01444261 study?
This clinical trial studies the following conditions: Anemia, Iron-deficiency.
What interventions are being tested in trial NCT01444261?
The interventions under investigation include: control (OTHER), Fer-in-Sol (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01444261?
This trial is sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01444261 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01444261's enrollment target sits among peer trials
219 32nd of 72 higher than 41 of 72 other Anemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Iron Deficiency Anemia (IDA) and the Brain
RECRUITING · Phase 4
-
Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
COMPLETED · Phase 4
-
Study of the Efficacy of Two Doses of Ferrlecit in the Treatment of Iron Deficiency in Pediatric Hemodialysis Patients
COMPLETED · Phase 4
-
A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease
COMPLETED · Phase 4
-
IV Iron Safety: Evaluation of Iron Species in Healthy Subjects
COMPLETED · Phase 4
-
Luspatercept for Anemia in Lower Risk MDS or Non-proliferative MDS/MPN Neoplasms
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05196035 · 219 participants · Phase 3
A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria
- NCT05608434 · 219 participants · Phase 1
Development of Virtual Reality-based Interventions to Strengthen Cognitive Skillsets Related to Attention Deficit Hyperactivity Disorder (ADHD): A Pilot Phase I and Randomized Controlled Phase II Trial
- NCT05773144 · 219 participants · NA
Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer
- NCT05907980 · 219 participants · Phase 1
A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia